Proposal for new drug user fee program addresses drug safety. (News).(Brief Article) From: Chemical Market Reporter | Date: March 11, 2002 | COPYRIGHT 2002 Schnell Publishing Company, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group.Copyright information

A LANDMARK DEAL worked out by the pharmaceutical industry and the Food & Drug Administration (FDA) would allow the fees that companies pay to the agency to speed up the drug approval process, and could be used to ensure the drugs' safety after they reach the market, sources told CMR last week.

The draft proposal, which the Bush administration has not yet officially approved, comes as Congress considers reauthorizing the Prescription Drug User Fee Act (PDUFA), which expir...